Cmax | Number of adverse events | Number of subjects | Probabilities | |||
---|---|---|---|---|---|---|
ATC subgroups | Below split point | Above split point | Below split point | Above split point | Below split point | Above split point |
Cardiovascular system | 17 | 17 | 173 | 154 | 0.098 | 0.110 |
Antiinfectives for systemic use | 11 | 14 | 162 | 249 | 0.068 | 0.055 |
Musculo-skeletal system | 11 | 10 | 136 | 188 | 0.081 | 0.053 |
Alimentary tract and metabolism | 27 | 66 | 109 | 241 | 0.248 | 0.274 |
Nervous system | 70 | 67 | 249 | 188 | 0.281 | 0.356 |
Respiratory system | 2 | 9 | 13 | 83 | 0.154 | 0.108 |
Genito-urinary system and sex hormones | 3 | 27 | 12 | 35 | 0.25 | 0.771 |